Search

everythinglearnresearchcommunity

for

Search:↓

Fat from the body can help improve hair growth and scars when used in skin treatments.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Early treatment of acne is crucial to prevent scarring and psychological effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Melatonin directly affects mouse hair follicles and may influence hair growth.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Rice bran oil extracted by supercritical CO2 is considered non-genotoxic.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Laser therapy on human skin affects the HERC6 gene and related genes, influencing many cell processes and requiring careful safety measures.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.